Diagnostics group is probably talking to Bio-Rad about merger

Qiagen in Hilden

Is the merger with Bio-Rad coming? No comment was received from either Qiagen or Bio-Rad.

(Photo: Reuters)

new York According to a media report, the two diagnostics groups Qiagen and Bio-Rad Laboratories are negotiating a merger. The talks have been going on for some time, the Wall Street Journal (WSJ) reported on Monday, citing people familiar with the matter.

However, an agreement is not expected in the next few weeks. Bio-Rad is valued at just under $13 billion on the stock exchange. There was initially no comment from either Qiagen, which has its operational headquarters in Hilden near Düsseldorf, or Bio-Rad.

U.S.-listed Qiagen shares jumped 8 percent in late Wall Street trading, while Bio-Rad shares fell nearly 10 percent.

source site-11